Head-to-head · WeighScore
Immortals vs MultiMedRx
The verdict
Immortals takes it — 61.8/100 to 57.6/100.
Immortals grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Immortals is a LegitScript-certified longevity telehealth platform founded by Bryan Johnson, offering compounded semaglutide (Semaglutide/Glycine/B12) and tirzepatide (Tirzepatide/Glycine/B12) as microdose…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Immortals | MultiMedRx |
|---|---|---|
| WeighScore | 61.8/100 | 57.6/100 |
| Grade | C | C |
| Scorecard rank | #284 | #393 |
| Semaglutide | $167/mo (microdose tier, compounded) | Not disclosed |
| Tirzepatide | $180/mo (microdose tier, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #284 · C
Strengths
- LegitScript certified (ID 50458743) with board-certified U.S. physician review within 72 hours
- Physician consult + prescription bundled in price — 'You pay for treatment. That's it' with no added fees
- Competitive pricing: semaglutide microdose from $167/month, tirzepatide from $180/month (promotional)
- Unlimited provider messaging for 12 months included; video consults available
- Founded by Bryan Johnson and Kate Tolo; clinical lead Dr. Carl Seger, M.D. (preventive/longevity medicine)
Where it loses points
- Microdose framing uses sub-clinical doses — lower weight-loss efficacy than standard GLP-1 protocols
- Quarterly commitment only — 3-month minimum, paid upfront ($501–$540/quarter); no monthly flexibility
- State availability not publicly listed; 'eligible U.S. states' with no specific state list
- Labs not included; baseline bloodwork protocol not disclosed on any public page
- Compounding pharmacy not named; no 503A/503B accreditation details disclosed
Graded #393 · C
Strengths
- Legal entity disclosed (MMRX MultiMedRx LLC) — uncommon transparency
- Two physical addresses listed: Newport Beach, CA and Reno, NV
- LegitScript seal present
- Features brand-name GLP-1s (Ozempic, Wegovy, Zepbound) — rare in a mostly compounded-only field
- Broader cardiometabolic menu (metformin, testosterone, HRT) alongside GLP-1
Where it loses points
- No Mounjaro or Foundayo in the brand-name lineup (only Ozempic, Wegovy, Zepbound)
- Monthly GLP-1 pricing isn't published — gated behind the consultation
- $100 consultation fee adds friction; many peers bundle it into the medication price
- Per-state availability not listed; only CA and NV offices disclosed
- Whether compounded GLP-1 is offered isn't clear — verify during intake
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.